Celestica Key Executives
This section highlights Celestica's key executives, including their titles and compensation details.
Find Contacts at Celestica
(Showing 0 of )
Celestica Earnings
This section highlights Celestica's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Last Earnings Results
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|---|---|---|---|---|
| Read Transcript | Q4 | 2024 | 2025-01-30 | N/A | N/A |
| Read Transcript | Q2 | 2024 | 2024-07-25 | N/A | N/A |
| Read Transcript | Q1 | 2024 | 2024-04-25 | N/A | N/A |
| Read Transcript | Q4 | 2023 | 2024-01-30 | N/A | N/A |
| Read Transcript | Q3 | 2023 | 2023-10-26 | N/A | N/A |
| Read Transcript | Q2 | 2023 | 2023-07-27 | N/A | N/A |
| Read Transcript | Q1 | 2023 | 2023-04-27 | N/A | N/A |
Celestica Inc. provides hardware platform and supply chain solutions in North America, Europe, and Asia. It operates through two segments, Advanced Technology Solutions, and Connectivity & Cloud Solutions. The company offers a range of product manufacturing and related supply chain services, including design and development, engineering, supply chain management, new product introduction, component sourcing, electronics manufacturing and assembly, testing, complex mechanical assembly, systems integration, precision machining, order fulfillment, logistics, asset management, product licensing, and after-market repair and return services. It also provides enterprise-level data communications and information processing infrastructure products, such as routers, switches, data center interconnects, edge solutions, servers, and storage-related products; capacitors, microprocessors, resistors, and memory modules; and power inverters, energy storage products, smart meters, and other electronic componentry products. The company serves aerospace and defense, industrial, energy, healthtech, capital equipment, original equipment manufacturers, cloud-based, and other service providers, including hyperscalers, and other companies in a range of industries. Celestica Inc. was incorporated in 1994 and is headquartered in Toronto, Canada.
$95.95
Stock Price
$11.13B
Market Cap
26.86K
Employees
Toronto, ON
Location
Financial Statements
Access annual & quarterly financial statements for Celestica, including income statements, balance sheets, and cash flow statements..
Annual Income Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Revenue | $9.65B | $7.96B | $7.25B | $5.63B | $5.75B |
| Cost of Revenue | $8.61B | $7.18B | $6.61B | $5.15B | $5.31B |
| Gross Profit | $1.03B | $778.50M | $636.30M | $487.00M | $437.60M |
| Gross Profit Ratio | 10.72% | 9.80% | 8.78% | 8.60% | 7.61% |
| Research and Development Expenses | $78.00M | $60.90M | $46.30M | $38.40M | $29.90M |
| General and Administrative Expenses | $- | $- | $- | $245.10M | $230.70M |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $293.50M | $279.60M | $279.90M | $245.10M | $230.70M |
| Other Expenses | $62.90M | $54.80M | $40.10M | $25.50M | $25.60M |
| Operating Expenses | $434.40M | $395.30M | $366.30M | $309.00M | $286.20M |
| Cost and Expenses | $9.05B | $7.58B | $6.98B | $5.46B | $5.60B |
| Interest Income | $- | $- | $59.70M | $31.70M | $37.70M |
| Interest Expense | $52.10M | $76.60M | $59.70M | $31.70M | $37.70M |
| Depreciation and Amortization | $151.90M | $160.40M | $139.06M | $125.19M | $131.29M |
| EBITDA | $736.20M | $543.60M | $263.30M | $167.70M | $127.90M |
| EBITDA Ratio | 7.63% | 6.83% | 5.72% | 5.35% | 4.80% |
| Operating Income | $599.30M | $383.20M | $263.30M | $167.70M | $127.90M |
| Operating Income Ratio | 6.21% | 4.81% | 3.63% | 2.98% | 2.23% |
| Total Other Income Expenses Net | $-67.10M | $-76.60M | $-59.70M | $-31.70M | $-37.70M |
| Income Before Tax | $532.20M | $306.60M | $203.60M | $136.00M | $90.20M |
| Income Before Tax Ratio | 5.52% | 3.85% | 2.81% | 2.41% | 1.57% |
| Income Tax Expense | $104.20M | $62.00M | $58.10M | $32.10M | $29.60M |
| Net Income | $428.00M | $244.60M | $145.50M | $103.90M | $60.60M |
| Net Income Ratio | 4.44% | 3.07% | 2.01% | 1.84% | 1.05% |
| EPS | $3.62 | $2.04 | $1.13 | $0.81 | $0.49 |
| EPS Diluted | $3.61 | $2.03 | $1.13 | $0.81 | $0.49 |
| Weighted Average Shares Outstanding | 118.10M | 120.10M | 123.50M | 126.70M | 129.10M |
| Weighted Average Shares Outstanding Diluted | 118.70M | 120.30M | 123.60M | 126.70M | 129.10M |
| SEC Filing | Source | Source | Source | Source | Source |
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.55B | $2.50B | $2.39B | $2.20B | $2.20B | $2.04B | $1.94B | $1.84B | $2.04B | $1.92B | $1.72B | $1.57B | $1.51B | $1.47B | $1.42B | $1.23B | $1.39B | $1.55B | $1.49B | $1.32B |
| Cost of Revenue | $2.26B | $2.24B | $2.15B | $1.98B | $1.98B | $1.84B | $1.75B | $1.67B | $1.86B | $1.76B | $1.57B | $1.43B | $1.37B | $1.34B | $1.30B | $1.13B | $1.27B | $1.43B | $1.38B | $1.23B |
| Gross Profit | $289.70M | $259.10M | $245.35M | $217.62M | $219.30M | $206.70M | $184.60M | $164.00M | $186.20M | $167.70M | $149.90M | $132.50M | $142.10M | $125.40M | $118.00M | $101.50M | $113.80M | $124.20M | $108.60M | $91.00M |
| Gross Profit Ratio | 11.38% | 10.40% | 10.30% | 9.90% | 10.00% | 10.10% | 9.50% | 8.90% | 9.10% | 8.70% | 8.70% | 8.50% | 9.40% | 8.50% | 8.30% | 8.20% | 8.21% | 8.01% | 7.28% | 6.90% |
| Research and Development Expenses | $23.40M | $18.85M | $19.40M | $16.43M | $18.09M | $16.90M | $14.30M | $12.10M | $14.50M | $11.60M | $8.80M | $11.40M | $10.60M | $10.00M | $9.00M | $8.80M | $8.40M | $8.10M | $6.60M | $6.80M |
| General and Administrative Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $57.60M | $91.90M | $80.08M | $64.91M | $77.79M | $56.90M | $69.10M | $77.90M | $77.10M | $66.10M | $71.00M | $65.70M | $65.50M | $62.00M | $58.80M | $58.80M | $59.40M | $56.90M | $58.00M | $56.40M |
| Other Expenses | $15.00M | $11.95M | $20.80M | $1.30M | $- | $-800.00K | $1.70M | $10.00M | $10.20M | $10.00M | $9.90M | $10.00M | $8.70M | $5.60M | $5.60M | $5.60M | $6.00M | $6.30M | $6.60M | $6.70M |
| Operating Expenses | $94.70M | $122.70M | $99.48M | $81.34M | $95.88M | $83.70M | $93.30M | $100.00M | $101.80M | $87.70M | $89.70M | $87.10M | $84.80M | $77.60M | $73.40M | $73.20M | $73.80M | $71.30M | $71.20M | $69.90M |
| Cost and Expenses | $2.35B | $2.36B | $2.25B | $2.06B | $2.08B | $1.92B | $1.85B | $1.77B | $1.96B | $1.84B | $1.66B | $1.52B | $1.45B | $1.42B | $1.38B | $1.21B | $1.35B | $1.50B | $1.46B | $1.30B |
| Interest Income | $-8.50M | $1.90M | $6.20M | $- | $- | $18.30M | $22.10M | $21.70M | $19.30M | $17.50M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Interest Expense | $400.00K | $12.90M | $21.90M | $16.50M | $14.90M | $18.30M | $22.10M | $21.70M | $19.30M | $17.50M | $13.10M | $9.80M | $8.30M | $7.80M | $7.60M | $8.00M | $9.10M | $8.90M | $8.90M | $10.80M |
| Depreciation and Amortization | $15.50M | $47.80M | $44.99M | $43.41M | $44.50M | $38.90M | $39.92M | $38.30M | $37.56M | $33.51M | $35.59M | $36.34M | $34.68M | $30.39M | $30.34M | $30.30M | $30.80M | $31.20M | $31.30M | $31.40M |
| EBITDA | $187.00M | $186.10M | $186.96M | $179.69M | $166.37M | $161.60M | $128.88M | $97.71M | $119.10M | $115.50M | $96.10M | $77.44M | $84.70M | $81.74M | $72.38M | $54.00M | $66.30M | $80.40M | $61.40M | $52.50M |
| EBITDA Ratio | 7.35% | 7.45% | 7.98% | 8.17% | 7.63% | 7.95% | 6.74% | 5.57% | 5.97% | 6.01% | 5.60% | 5.19% | 5.89% | 5.34% | 5.29% | 4.75% | 5.11% | 5.42% | 4.60% | 3.98% |
| Operating Income | $202.60M | $136.40M | $145.87M | $136.29M | $123.42M | $117.40M | $87.80M | $59.40M | $81.60M | $78.40M | $62.70M | $40.60M | $49.90M | $51.70M | $42.40M | $23.70M | $35.50M | $49.20M | $30.10M | $13.10M |
| Operating Income Ratio | 7.96% | 5.46% | 6.10% | 6.20% | 5.61% | 5.75% | 4.53% | 3.23% | 3.99% | 4.08% | 3.65% | 2.59% | 3.30% | 3.52% | 2.99% | 1.92% | 2.56% | 3.17% | 2.02% | 0.99% |
| Total Other Income Expenses Net | $-13.10M | $-11.00M | $-15.70M | $-16.50M | $-14.50M | $-18.30M | $-22.10M | $-21.70M | $-19.30M | $-17.50M | $-13.10M | $-9.80M | $-8.30M | $-7.80M | $-7.60M | $-8.00M | $-9.10M | $-8.90M | $-8.90M | $-10.80M |
| Income Before Tax | $189.50M | $125.40M | $120.08M | $115.08M | $106.98M | $99.10M | $65.70M | $37.70M | $62.30M | $60.90M | $49.60M | $30.80M | $41.60M | $43.90M | $34.80M | $15.70M | $26.40M | $40.30M | $21.20M | $2.30M |
| Income Before Tax Ratio | 7.44% | 5.02% | 5.02% | 5.23% | 4.86% | 4.85% | 3.39% | 2.05% | 3.05% | 3.17% | 2.89% | 1.97% | 2.75% | 2.99% | 2.45% | 1.27% | 1.90% | 2.60% | 1.42% | 0.17% |
| Income Tax Expense | $37.80M | $33.70M | $20.50M | $13.84M | $20.45M | $18.90M | $10.20M | $13.00M | $19.90M | $15.20M | $14.00M | $9.00M | $9.70M | $8.70M | $8.50M | $5.20M | $6.30M | $9.90M | $7.90M | $5.50M |
| Net Income | $135.00M | $91.70M | $99.60M | $101.70M | $84.20M | $80.20M | $55.50M | $24.70M | $42.40M | $45.70M | $35.60M | $21.80M | $31.90M | $35.20M | $26.30M | $10.50M | $20.10M | $30.40M | $13.30M | $-3.20M |
| Net Income Ratio | 5.30% | 3.67% | 4.16% | 4.62% | 3.83% | 3.93% | 2.86% | 1.34% | 2.08% | 2.38% | 2.07% | 1.39% | 2.11% | 2.40% | 1.85% | 0.85% | 1.45% | 1.96% | 0.89% | -0.24% |
| EPS | $1.30 | $0.78 | $0.84 | $0.85 | $0.73 | $0.66 | $0.47 | $0.20 | $0.35 | $0.37 | $0.29 | $0.17 | $0.26 | $0.28 | $0.21 | $0.08 | $0.16 | $0.24 | $0.10 | $-0.02 |
| EPS Diluted | $1.29 | $0.77 | $0.83 | $0.85 | $0.72 | $0.66 | $0.47 | $0.20 | $0.35 | $0.37 | $0.29 | $0.17 | $0.26 | $0.28 | $0.21 | $0.08 | $0.16 | $0.24 | $0.10 | $-0.02 |
| Weighted Average Shares Outstanding | 116.30M | 118.20M | 118.80M | 119.00M | 119.30M | 119.30M | 120.30M | 121.50M | 122.30M | 123.10M | 124.00M | 124.60M | 124.80M | 125.40M | 127.60M | 128.90M | 129.10M | 129.10M | 129.10M | 129.00M |
| Weighted Average Shares Outstanding Diluted | 117.30M | 118.90M | 119.40M | 119.30M | 119.50M | 119.60M | 120.30M | 121.60M | 122.40M | 123.20M | 124.00M | 124.70M | 124.80M | 125.50M | 127.60M | 129.00M | 129.10M | 129.10M | 129.10M | 129.00M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Cash and Cash Equivalents | $423.30M | $370.40M | $374.50M | $394.00M | $463.80M |
| Short Term Investments | $- | $2.20M | $- | $- | $- |
| Cash and Short Term Investments | $423.30M | $372.60M | $374.50M | $394.00M | $463.80M |
| Net Receivables | $2.07B | $1.80B | $1.39B | $1.26B | $1.10B |
| Inventory | $1.76B | $2.11B | $2.35B | $1.70B | $1.09B |
| Other Current Assets | $259.30M | $238.20M | $208.70M | $84.00M | $81.70M |
| Total Current Assets | $4.51B | $4.51B | $4.33B | $3.44B | $2.74B |
| Property Plant Equipment Net | $661.60M | $626.80M | $510.30M | $452.50M | $433.50M |
| Goodwill | $340.50M | $321.70M | $321.80M | $324.20M | $198.60M |
| Intangible Assets | $308.00M | $325.20M | $346.50M | $382.00M | $229.40M |
| Goodwill and Intangible Assets | $648.50M | $646.90M | $668.30M | $706.20M | $428.00M |
| Long Term Investments | $- | $10.94M | $18.69M | $- | $- |
| Tax Assets | $87.70M | $62.18M | $68.90M | $47.70M | $39.90M |
| Other Non-Current Assets | $78.20M | $31.38M | $34.81M | $25.20M | $25.50M |
| Total Non-Current Assets | $1.48B | $1.38B | $1.30B | $1.23B | $926.90M |
| Other Assets | $- | $-100.00K | $- | $- | $- |
| Total Assets | $5.99B | $5.89B | $5.63B | $4.67B | $3.66B |
| Account Payables | $1.29B | $1.30B | $1.44B | $1.24B | $854.50M |
| Short Term Debt | $26.50M | $51.60M | $52.20M | $51.50M | $132.00M |
| Tax Payables | $93.50M | $64.47M | $82.10M | $62.30M | $51.80M |
| Deferred Revenue | $- | $- | $68.90M | $47.70M | $39.90M |
| Other Current Liabilities | $1.61B | $1.81B | $1.48B | $901.40M | $539.90M |
| Total Current Liabilities | $3.02B | $3.22B | $3.06B | $2.25B | $1.58B |
| Long Term Debt | $770.20M | $731.20M | $733.90M | $742.90M | $486.10M |
| Deferred Revenue Non-Current | $- | $215.91K | $51.70M | $135.50M | $32.30M |
| Deferred Tax Liabilities Non-Current | $49.40M | $41.98M | $51.70M | $60.20M | $32.30M |
| Other Non-Current Liabilities | $251.20M | $129.30M | $109.50M | $147.30M | $158.50M |
| Total Non-Current Liabilities | $1.07B | $902.70M | $895.10M | $950.40M | $676.90M |
| Other Liabilities | $- | $- | $- | $- | $- |
| Total Liabilities | $4.09B | $4.12B | $3.95B | $3.20B | $2.26B |
| Preferred Stock | $- | $- | $- | $- | $- |
| Common Stock | $- | $1.67B | $1.71B | $1.76B | $1.83B |
| Retained Earnings | $-423.80M | $-839.60M | $-1.08B | $-1.26B | $-1.37B |
| Accumulated Other Comprehensive Income Loss | $-17.60M | $-14.82M | $-1.30M | $-26.80M | $-15.20M |
| Other Total Stockholders Equity | $2.34B | $950.42M | $1.05B | $980.90M | $958.80M |
| Total Stockholders Equity | $1.90B | $1.77B | $1.68B | $1.46B | $1.41B |
| Total Equity | $1.90B | $1.77B | $1.68B | $1.46B | $1.41B |
| Total Liabilities and Stockholders Equity | $5.99B | $5.89B | $5.63B | $4.67B | $3.66B |
| Minority Interest | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $5.99B | $5.89B | $5.63B | $4.67B | $3.66B |
| Total Investments | $9.70M | $10.94M | $18.69M | $- | $- |
| Total Debt | $796.70M | $782.80M | $786.10M | $794.40M | $585.90M |
| Net Debt | $373.40M | $412.40M | $411.60M | $400.40M | $122.10M |
Balance Sheet Charts
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $423.30M | $398.50M | $433.94M | $307.78M | $368.50M | $353.10M | $360.70M | $318.70M | $374.50M | $363.30M | $365.50M | $346.60M | $394.00M | $477.20M | $467.20M | $449.40M | $463.80M | $451.40M | $435.90M | $472.10M |
| Short Term Investments | $- | $- | $- | $- | $2.20M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Cash and Short Term Investments | $423.30M | $398.50M | $433.94M | $307.78M | $368.50M | $353.10M | $360.70M | $318.70M | $374.50M | $363.30M | $365.50M | $346.60M | $394.00M | $477.20M | $467.20M | $449.40M | $463.80M | $451.40M | $435.90M | $472.10M |
| Net Receivables | $2.07B | $2.02B | $1.90B | $1.82B | $1.80B | $1.60B | $1.30B | $1.27B | $1.39B | $1.16B | $1.21B | $1.24B | $1.26B | $1.15B | $1.09B | $971.60M | $1.10B | $1.13B | $1.14B | $988.30M |
| Inventory | $1.76B | $1.83B | $1.85B | $1.96B | $2.10B | $2.26B | $2.35B | $2.40B | $2.35B | $2.33B | $2.11B | $1.93B | $1.70B | $1.41B | $1.22B | $1.15B | $1.09B | $1.21B | $1.21B | $1.07B |
| Other Current Assets | $259.30M | $220.30M | $249.00M | $239.84M | $238.20M | $212.50M | $186.60M | $188.50M | $208.70M | $220.90M | $213.10M | $105.60M | $84.00M | $72.00M | $56.00M | $66.20M | $81.70M | $73.40M | $68.20M | $57.80M |
| Total Current Assets | $4.51B | $4.47B | $4.43B | $4.32B | $4.49B | $4.43B | $4.20B | $4.18B | $4.33B | $4.07B | $3.90B | $3.63B | $3.44B | $3.10B | $2.84B | $2.64B | $2.74B | $2.86B | $2.85B | $2.59B |
| Property Plant Equipment Net | $661.60M | $646.00M | $661.30M | $647.33M | $623.49M | $552.30M | $531.30M | $509.20M | $510.30M | $483.50M | $463.90M | $436.00M | $452.50M | $435.10M | $419.40M | $423.50M | $433.50M | $435.30M | $436.90M | $444.00M |
| Goodwill | $340.50M | $341.00M | $340.85M | $321.17M | $320.05M | $321.50M | $321.60M | $321.60M | $321.80M | $321.30M | $321.70M | $321.90M | $324.20M | $198.20M | $198.40M | $198.40M | $198.60M | $198.30M | $198.20M | $198.10M |
| Intangible Assets | $308.00M | $320.00M | $330.30M | $309.20M | $325.20M | $317.60M | $327.00M | $336.60M | $346.50M | $356.10M | $365.50M | $375.30M | $382.00M | $216.40M | $220.10M | $224.60M | $229.40M | $234.60M | $240.20M | $245.00M |
| Goodwill and Intangible Assets | $648.50M | $661.00M | $671.20M | $630.70M | $646.90M | $639.10M | $648.60M | $658.20M | $668.30M | $677.40M | $687.20M | $697.20M | $706.20M | $414.60M | $418.50M | $423.00M | $428.00M | $432.90M | $438.40M | $443.10M |
| Long Term Investments | $- | $2 | $330.25M | $308.88M | $10.94M | $- | $- | $- | $18.69M | $19.60M | $- | $5.50M | $- | $100.00K | $200.00K | $300.00K | $- | $- | $- | $- |
| Tax Assets | $87.70M | $74.30M | $69.39M | $65.43M | $62.18M | $74.50M | $72.10M | $72.50M | $68.90M | $66.70M | $55.40M | $52.70M | $47.70M | $51.10M | $43.40M | $41.40M | $39.90M | $36.10M | $38.00M | $35.50M |
| Other Non-Current Assets | $78.20M | $76.80M | $-281.86M | $-263.48M | $27.53M | $53.70M | $51.90M | $52.30M | $34.81M | $29.00M | $36.50M | $26.20M | $25.20M | $22.00M | $23.20M | $24.40M | $25.50M | $24.90M | $24.70M | $24.60M |
| Total Non-Current Assets | $1.48B | $1.46B | $1.45B | $1.39B | $1.37B | $1.32B | $1.30B | $1.29B | $1.30B | $1.28B | $1.24B | $1.22B | $1.23B | $922.90M | $904.70M | $912.60M | $926.90M | $929.20M | $938.00M | $947.20M |
| Other Assets | $- | $- | $1 | $- | $1 | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Assets | $5.99B | $5.93B | $5.88B | $5.71B | $5.86B | $5.75B | $5.50B | $5.47B | $5.63B | $5.35B | $5.14B | $4.85B | $4.67B | $4.03B | $3.75B | $3.55B | $3.66B | $3.79B | $3.79B | $3.54B |
| Account Payables | $1.29B | $1.39B | $1.37B | $1.39B | $1.30B | $1.32B | $1.28B | $1.34B | $1.44B | $1.48B | $1.51B | $1.40B | $1.24B | $1.10B | $964.40M | $857.90M | $854.50M | $1.05B | $1.12B | $932.00M |
| Short Term Debt | $1.61B | $57.70M | $61.80M | $54.30M | $51.60M | $51.20M | $65.40M | $51.10M | $52.20M | $51.40M | $69.50M | $59.60M | $51.50M | $55.70M | $32.90M | $83.60M | $132.00M | $26.30M | $28.30M | $37.90M |
| Tax Payables | $93.50M | $85.70M | $83.99M | $65.63M | $64.47M | $60.60M | $63.10M | $88.80M | $82.10M | $68.20M | $71.40M | $67.00M | $62.30M | $54.50M | $48.00M | $44.90M | $51.80M | $49.60M | $48.00M | $37.70M |
| Deferred Revenue | $- | $- | $83.99M | $65.63M | $64.47M | $- | $- | $- | $68.90M | $- | $- | $- | $47.70M | $54.50M | $48.00M | $44.90M | $39.90M | $49.60M | $48.00M | $37.70M |
| Other Current Liabilities | $19.90M | $1.50B | $1.50B | $1.54B | $1.81B | $1.66B | $1.53B | $1.45B | $1.48B | $1.25B | $1.03B | $880.20M | $901.40M | $650.90M | $515.40M | $504.20M | $539.90M | $491.90M | $471.20M | $390.10M |
| Total Current Liabilities | $3.02B | $3.04B | $3.01B | $3.04B | $3.20B | $3.10B | $2.94B | $2.92B | $3.06B | $2.85B | $2.68B | $2.41B | $2.25B | $1.86B | $1.66B | $1.49B | $1.58B | $1.71B | $1.76B | $1.47B |
| Long Term Debt | $937.60M | $883.40M | $889.87M | $777.60M | $727.46M | $900.72M | $886.21M | $880.10M | $733.90M | $741.10M | $734.90M | $728.00M | $750.30M | $526.30M | $594.90M | $483.20M | $486.10M | $620.30M | $606.40M | $666.10M |
| Deferred Revenue Non-Current | $- | $- | $210.77M | $202.39M | $141.17M | $79.40M | $- | $- | $51.70M | $- | $- | $- | $60.20M | $- | $- | $- | $32.30M | $- | $- | $- |
| Deferred Tax Liabilities Non-Current | $49.40M | $41.90M | $40.89M | $46.95M | $41.98M | $50.90M | $47.50M | $49.50M | $51.70M | $52.30M | $54.30M | $61.10M | $60.20M | $28.70M | $29.20M | $27.70M | $32.30M | $26.40M | $27.40M | $32.50M |
| Other Non-Current Liabilities | $83.80M | $145.00M | $-32.90M | $-22.28M | $170.62M | $-67.72M | $-2.31M | $7.50M | $109.50M | $188.20M | $194.40M | $203.60M | $139.90M | $174.00M | $36.30M | $169.00M | $158.50M | $28.60M | $31.60M | $27.20M |
| Total Non-Current Liabilities | $1.07B | $1.07B | $1.07B | $957.71M | $898.08M | $912.40M | $883.90M | $887.60M | $895.10M | $929.30M | $929.30M | $931.60M | $950.40M | $700.30M | $660.40M | $652.20M | $676.90M | $675.30M | $665.40M | $725.80M |
| Other Liabilities | $- | $- | $- | $- | $1 | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $4.09B | $4.11B | $4.08B | $4.00B | $4.10B | $4.01B | $3.82B | $3.81B | $3.95B | $3.78B | $3.61B | $3.34B | $3.20B | $2.56B | $2.32B | $2.14B | $2.26B | $2.39B | $2.43B | $2.20B |
| Preferred Stock | $- | $31.77K | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock | $- | $1.64B | $1.67B | $1.67B | $1.66B | $1.68B | $1.68B | $1.70B | $1.71B | $1.73B | $1.74B | $1.75B | $1.76B | $1.76B | $1.80B | $1.82B | $1.83B | $1.83B | $1.83B | $1.83B |
| Retained Earnings | $-423.80M | $-546.60M | $-638.21M | $-737.14M | $-835.30M | $-916.20M | $-996.40M | $-1.05B | $-1.08B | $-1.15B | $-1.20B | $-1.23B | $-1.26B | $-1.30B | $-1.33B | $-1.36B | $-1.37B | $-1.38B | $-1.41B | $-1.42B |
| Accumulated Other Comprehensive Income Loss | $-17.60M | $-20.07M | $-33.80M | $-23.88M | $-14.82M | $-26.00M | $-14.80M | $-9.70M | $-1.30M | $-30.00M | $-24.70M | $-16.10M | $-26.80M | $-31.50M | $-26.50M | $-26.20M | $-15.20M | $-28.30M | $-34.30M | $-49.40M |
| Other Total Stockholders Equity | $2.34B | $749.34M | $807.00M | $801.80M | $941.45M | $1.00B | $1.01B | $1.02B | $1.05B | $1.02B | $1.01B | $1.01B | $980.90M | $1.03B | $988.80M | $971.00M | $958.80M | $974.30M | $972.30M | $977.30M |
| Total Stockholders Equity | $1.90B | $1.82B | $1.80B | $1.71B | $1.76B | $1.74B | $1.68B | $1.66B | $1.68B | $1.57B | $1.53B | $1.51B | $1.46B | $1.47B | $1.43B | $1.41B | $1.41B | $1.40B | $1.36B | $1.34B |
| Total Equity | $1.90B | $1.82B | $1.80B | $1.71B | $1.76B | $1.74B | $1.68B | $1.66B | $1.68B | $1.57B | $1.53B | $1.51B | $1.46B | $1.47B | $1.43B | $1.41B | $1.41B | $1.40B | $1.36B | $1.34B |
| Total Liabilities and Stockholders Equity | $5.99B | $5.93B | $5.88B | $5.71B | $5.86B | $5.75B | $5.50B | $5.47B | $5.63B | $5.35B | $5.14B | $4.85B | $4.67B | $4.03B | $3.75B | $3.55B | $3.66B | $3.79B | $3.79B | $3.54B |
| Minority Interest | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $5.99B | $5.93B | $5.88B | $5.71B | $5.86B | $5.75B | $5.50B | $5.47B | $5.63B | $5.35B | $5.14B | $4.85B | $4.67B | $4.03B | $3.75B | $3.55B | $3.66B | $3.79B | $3.79B | $3.54B |
| Total Investments | $9.70M | $2 | $330.25M | $308.88M | $10.94M | $- | $- | $- | $18.69M | $19.60M | $- | $5.50M | $- | $100.00K | $200.00K | $300.00K | $- | $- | $- | $- |
| Total Debt | $2.55B | $941.10M | $951.66M | $831.84M | $778.79M | $790.30M | $783.40M | $775.20M | $786.10M | $792.50M | $804.40M | $785.70M | $794.40M | $571.80M | $555.00M | $553.30M | $585.90M | $579.30M | $572.20M | $631.90M |
| Net Debt | $2.13B | $542.60M | $517.72M | $524.06M | $410.29M | $437.20M | $422.70M | $456.50M | $411.60M | $429.20M | $438.90M | $439.10M | $400.40M | $94.60M | $87.80M | $103.90M | $122.10M | $127.90M | $136.30M | $159.80M |
Annual Cash Flow
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Net Income | $428.00M | $244.60M | $145.50M | $103.90M | $60.60M |
| Depreciation and Amortization | $151.90M | $163.34M | $144.80M | $126.30M | $124.70M |
| Deferred Income Tax | $-31.90M | $62.00M | $58.10M | $32.10M | $29.60M |
| Stock Based Compensation | $57.40M | $58.00M | $51.00M | $33.40M | $25.80M |
| Change in Working Capital | $-70.70M | $-42.70M | $-88.80M | $-78.90M | $-23.50M |
| Accounts Receivables | $-270.70M | $-409.58M | $-133.30M | $-102.40M | $-40.70M |
| Inventory | $343.70M | $248.68M | $-717.30M | $-521.90M | $-99.30M |
| Accounts Payables | $- | $108.45M | $813.40M | $556.90M | $117.00M |
| Other Working Capital | $-143.70M | $9.74M | $-51.60M | $-11.50M | $-500.00K |
| Other Non Cash Items | $-60.80M | $-114.36M | $-12.70M | $10.00M | $22.40M |
| Net Cash Provided by Operating Activities | $473.90M | $370.88M | $297.90M | $226.80M | $239.60M |
| Investments in Property Plant and Equipment | $-170.90M | $-125.10M | $-109.00M | $-52.20M | $-52.80M |
| Acquisitions Net | $-36.10M | $- | $96.04K | $-314.70M | $1.90M |
| Purchases of Investments | $- | $- | $- | $- | $- |
| Sales Maturities of Investments | $- | $- | $- | $- | $- |
| Other Investing Activities | $-5.50M | $2.70M | $3.96K | $2.60M | $-95.09K |
| Net Cash Used for Investing Activities | $-212.50M | $-122.40M | $-108.90M | $-364.30M | $-51.00M |
| Debt Repayment | $122.60M | $-66.60M | $-31.88M | $150.00M | $-155.60M |
| Common Stock Issued | $3.90M | $305.50K | $200.00K | $200.00K | $- |
| Common Stock Repurchased | $-152.00M | $-35.60M | $-34.60M | $-35.90M | $-100.00K |
| Dividends Paid | $- | $- | $- | $- | $- |
| Other Financing Activities | $-183.00M | $-209.50M | $-142.22M | $-46.60M | $-48.60M |
| Net Cash Used Provided by Financing Activities | $-208.50M | $-311.40M | $-208.50M | $67.70M | $-204.30M |
| Effect of Forex Changes on Cash | $- | $- | $- | $- | $- |
| Net Change in Cash | $52.90M | $-4.10M | $-19.50M | $-69.80M | $-15.70M |
| Cash at End of Period | $423.30M | $370.40M | $374.50M | $394.00M | $463.80M |
| Cash at Beginning of Period | $370.40M | $374.50M | $394.00M | $463.80M | $479.50M |
| Operating Cash Flow | $473.90M | $429.70M | $297.90M | $226.80M | $239.60M |
| Capital Expenditure | $-170.90M | $-125.10M | $-109.00M | $-52.20M | $-52.80M |
| Free Cash Flow | $303.00M | $304.60M | $188.90M | $174.60M | $186.80M |
Cash Flow Charts
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $151.70M | $92.44M | $99.58M | $101.25M | $86.53M | $80.20M | $55.50M | $24.70M | $42.40M | $45.70M | $35.60M | $21.80M | $31.90M | $35.20M | $26.30M | $10.50M | $20.10M | $30.40M | $13.30M | $-3.20M |
| Depreciation and Amortization | $40.00M | $48.18M | $44.99M | $43.41M | $44.50M | $39.40M | $39.40M | $38.30M | $37.50M | $35.50M | $35.90M | $35.90M | $34.80M | $30.60M | $30.60M | $30.30M | $30.80M | $31.20M | $31.30M | $31.40M |
| Deferred Income Tax | $-9.90M | $33.70M | $-17.85M | $2.59M | $2.74M | $18.90M | $10.20M | $13.00M | $19.90M | $15.20M | $14.00M | $9.00M | $9.70M | $8.70M | $8.50M | $5.20M | $6.30M | $9.90M | $7.90M | $5.50M |
| Stock Based Compensation | $10.10M | $12.70M | $11.90M | $22.70M | $9.80M | $12.90M | $10.90M | $22.00M | $14.20M | $9.00M | $13.20M | $14.60M | $9.20M | $8.60M | $5.50M | $10.10M | $5.10M | $1.70M | $7.70M | $11.30M |
| Change in Working Capital | $- | $-27.50M | $-36.18M | $-19.51M | $-2.22M | $-31.10M | $30.60M | $-40.10M | $-12.70M | $-19.70M | $-8.80M | $-47.60M | $-23.40M | $-26.60M | $-26.20M | $-2.70M | $-18.80M | $-41.70M | $9.80M | $27.20M |
| Accounts Receivables | $-61.30M | $-111.70M | $-80.43M | $-16.72M | $-200.74M | $-295.30M | $-43.70M | $133.50M | $-231.90M | $49.40M | $32.30M | $16.90M | $-47.70M | $-61.20M | $-121.90M | $128.40M | $31.60M | $10.40M | $-150.80M | $68.10M |
| Inventory | $59.90M | $25.50M | $106.50M | $146.24M | $158.03M | $84.50M | $57.70M | $-53.00M | $6.70M | $-222.40M | $-263.80M | $-237.80M | $-207.50M | $-181.00M | $-71.30M | $-62.10M | $113.70M | $900.00K | $-133.70M | $-80.20M |
| Accounts Payables | $- | $21.00M | $-71.60M | $-138.98M | $54.59M | $186.30M | $-4.10M | $-129.20M | $221.80M | $156.50M | $251.30M | $183.80M | $236.20M | $226.50M | $161.50M | $-67.30M | $-170.70M | $-48.10M | $296.50M | $39.30M |
| Other Working Capital | $- | $37.70M | $9.36M | $-10.05M | $-14.11M | $-6.60M | $20.70M | $8.60M | $-9.30M | $-3.20M | $-28.60M | $-10.50M | $-4.40M | $-10.90M | $5.50M | $-1.70M | $6.60M | $-4.90M | $-2.20M | $- |
| Other Non Cash Items | $-48.50M | $-26.06M | $146.30M | $85.32M | $-11.41M | $-31.90M | $-16.40M | $14.40M | $98.96M | $-11.30M | $-3.00M | $1.60M | $3.60M | $-800.00K | $11.80M | $-4.60M | $6.20M | $10.50M | $-5.40M | $11.10M |
| Net Cash Provided by Operating Activities | $143.40M | $133.46M | $101.32M | $116.78M | $129.93M | $88.40M | $130.20M | $72.30M | $101.30M | $74.40M | $86.90M | $35.30M | $65.80M | $55.70M | $56.50M | $48.80M | $49.70M | $42.00M | $64.60M | $83.30M |
| Investments in Property Plant and Equipment | $-47.60M | $-46.19M | $-36.93M | $-40.22M | $-33.70M | $-27.00M | $-32.10M | $-33.10M | $-32.30M | $-38.70M | $-21.60M | $-16.40M | $-14.40M | $-15.70M | $-9.50M | $-12.60M | $-19.20M | $-10.10M | $-11.20M | $-12.30M |
| Acquisitions Net | $- | $- | $-32.96M | $- | $1.02M | $792.56K | $915.10K | $- | $1.39K | $813 | $98.75K | $- | $-314.70M | $2.47M | $- | $- | $- | $- | $- | $- |
| Purchases of Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Sales Maturities of Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Investing Activities | $-3.40M | $-5.02M | $2.90M | $- | $1 | $7.44K | $-15.10K | $- | $-1.39K | $-813 | $1.25K | $- | $100.00K | $2.50M | $- | $- | $400.00K | $200.00K | $1.10M | $100.00K |
| Net Cash Used for Investing Activities | $-51.00M | $-51.22M | $-69.88M | $-40.22M | $-32.68M | $-26.20M | $-31.20M | $-33.10M | $-32.30M | $-38.70M | $-21.50M | $-16.40M | $-329.00M | $-13.20M | $-9.50M | $-12.60M | $-18.80M | $-9.90M | $-10.10M | $-12.20M |
| Debt Repayment | $23.50M | $-17.40M | $104.80M | $11.70M | $-15.90M | $-17.40M | $-17.40M | $-15.90M | $-29.40M | $-17.60M | $-16.40M | $-4.66M | $-155.00M | $-10.00M | $-10.40M | $-39.60M | $-5.80M | $-9.90M | $-70.60M | $-69.30M |
| Common Stock Issued | $- | $209 | $28.47K | $3.90M | $631 | $300.00K | $- | $- | $100.00K | $- | $399 | $101.23K | $100.00K | $100.00K | $- | $- | $- | $- | $- | $- |
| Common Stock Repurchased | $-25.50M | $-100.00M | $-10.00M | $-16.50M | $-10.00M | $- | $-15.00M | $-10.60M | $-12.00M | $-5.00M | $-9.80M | $-7.80M | $- | $-17.20M | $-13.40M | $-5.30M | $-6.10M | $- | $-13.10M | $- |
| Dividends Paid | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Financing Activities | $-65.60M | $-485.64K | $-1.71M | $-137.68M | $-63.70M | $-52.70M | $-24.60M | $-68.50M | $-16.50M | $-15.30M | $-20.30M | $-53.94M | $334.90M | $-5.40M | $-5.40M | $-5.70M | $-6.60M | $-6.70M | $-7.00M | $-9.20M |
| Net Cash Used Provided by Financing Activities | $-67.60M | $-117.89M | $93.09M | $-138.58M | $-79.68M | $-69.80M | $-57.00M | $-95.00M | $-57.80M | $-37.90M | $-46.50M | $-66.30M | $180.00M | $-32.50M | $-29.20M | $-50.60M | $-18.50M | $-16.60M | $-90.70M | $-78.50M |
| Effect of Forex Changes on Cash | $- | $- | $- | $- | $-475.01K | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Net Change in Cash | $24.80M | $-35.50M | $126.15M | $-60.72M | $17.10M | $-7.60M | $42.00M | $-55.80M | $11.20M | $-2.20M | $18.90M | $-47.40M | $-83.20M | $10.00M | $17.80M | $-14.40M | $12.40M | $15.50M | $-36.20M | $-7.40M |
| Cash at End of Period | $423.30M | $398.50M | $433.94M | $307.78M | $368.50M | $353.10M | $360.70M | $318.70M | $374.50M | $363.30M | $365.50M | $346.60M | $394.00M | $477.20M | $467.20M | $449.40M | $463.80M | $451.40M | $435.90M | $472.10M |
| Cash at Beginning of Period | $398.50M | $434.00M | $307.78M | $368.50M | $351.41M | $360.70M | $318.70M | $374.50M | $363.30M | $365.50M | $346.60M | $394.00M | $477.20M | $467.20M | $449.40M | $463.80M | $451.40M | $435.90M | $472.10M | $479.50M |
| Operating Cash Flow | $143.40M | $144.80M | $101.32M | $116.78M | $129.93M | $88.40M | $130.20M | $72.30M | $101.30M | $74.40M | $86.90M | $35.30M | $65.80M | $55.70M | $56.50M | $48.80M | $49.70M | $42.00M | $64.60M | $83.30M |
| Capital Expenditure | $-47.60M | $-46.00M | $-36.93M | $-40.22M | $-33.70M | $-27.00M | $-32.10M | $-33.10M | $-32.30M | $-38.70M | $-21.60M | $-16.40M | $-14.40M | $-15.70M | $-9.50M | $-12.60M | $-19.20M | $-10.10M | $-11.20M | $-12.30M |
| Free Cash Flow | $95.80M | $98.80M | $64.39M | $76.56M | $96.23M | $61.40M | $98.10M | $39.20M | $69.00M | $35.70M | $65.30M | $18.90M | $51.40M | $40.00M | $47.00M | $36.20M | $30.50M | $31.90M | $53.40M | $71.00M |
Celestica Dividends
Explore Celestica's dividend history, including dividend yield, payout ratio, and historical payments.
Celestica News
Read the latest news about Celestica, including recent articles, headlines, and updates.
Clearside Biomedical's Lead Clinical Program CLS-AX in Wet AMD and Suprachoroidal Delivery Platform Highlighted at the 2025 Wet AMD & Diabetic Eye Disease Summit
- Post-Hoc Analyses Provide Comparative Data on Rescue Criteria and Intervention-Free Rates for Tyrosine Kinase Inhibitors (TKIs) in Wet AMD Development -
Celestica: My Top AI Connectivity Pick For 2025 - Why I Keep Adding (Rating Upgrade)
Celestica is my top AI Connectivity pick for 2025 due to booming AI business, strong management, and increased hyperscaler capex towards its cloud communication products. Celestica's CCS segment saw massive demand in 2024 with increasing market share, leading to upgraded 2025 revenue targets of $10.7 billion, driven by its Ethernet-based switches. Despite thin margins, Celestica's pivot to design and solution partnerships is enhancing margins and positioning the company for long-term rewards.
Celestica: The Overlooked AI Winner
Celestica reported Q4-CY24 revenue of $2.55B (+19% YoY), with CCS segment revenue surging 30% YoY to $1.74B. Full-year CY25 revenue is projected at $10.7B (+11% YoY), with adjusted EPS expected to hit $4.75 (+22% YoY). HPS within CCS grew 65% YoY, driven by AI-driven data center and networking demand.
Should You Invest in Celestica (CLS) Based on Bullish Wall Street Views?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Celestica: A Solid Buying Opportunity
Celestica is rated as a "Strong Buy" due to a 40% stock dip, presenting a golden buying opportunity for GARP investors. Despite tariff concerns, CLS's EPS growth, high operating margins, and strong demand from hyperscaler customers make the stock significantly undervalued by at least 31%. The company's transition to higher-value ODM services and robust CCS segment growth position it well for long-term stability and profitability.
Clearside Biomedical Announces Successful End-of-Phase 2 Meeting with the FDA and Alignment on Phase 3 Plans for Suprachoroidal CLS-AX in Wet AMD
- CLS-AX Phase 3 Program Designed to Maximize Commercial Potential in Wet AMD - - Flexible Dosing and Extended Duration would be Important Differentiators from Existing Approved Therapies and Other Tyrosine Kinase Inhibitors in Development - ALPHARETTA, Ga., March 06, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today the receipt of the formal meeting minutes from its recent End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) relating to CLS-AX (axitinib injectable suspension) for the treatment of neovascular age-related macular degeneration (wet AMD).
Celestica (CLS) Crossed Above the 50-Day Moving Average: What That Means for Investors
Celestica (CLS) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, CLS broke through the 50-day moving average, which suggests a short-term bullish trend.
Wall Street Analysts Believe Celestica (CLS) Could Rally 26.77%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 26.8% in Celestica (CLS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Celestica: Fueled By Relentless Catalysts
Celestica's strong Q4 performance and robust FY2025 guidance, driven by AI tailwinds and data center spending, support a "Strong buy" rating. The stock's valuation is attractive, with a DCF model indicating a 38% upside potential, even under conservative growth assumptions. Celestica's financial flexibility, low RSI levels, and significant momentum make it well-positioned for continued growth and value creation.
The Stocks And ETFs Driving Trump's Tariff Target Markets
Trump's tariffs cause short-term volatility, but long-term market impact is minimal; earnings remain the key focus for investors. The three countries in questions are Canada, China, and Mexico. This blog dives into several major companies domiciled in one of those three countries. In the long-term scheme of things the fundamentals of the companies behind these ADRs and stocks are likely to be more deterministic than any geopolitical factors.
Is It Worth Investing in Celestica (CLS) Based on Wall Street's Bullish Views?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Celestica: Management And Analysts Upped Guidance/Estimates Still Appear Conservative
Celestica's stock rating is adjusted from a strong buy to a buy due to a rapid share price increase and coming off seasonal strength. The CCS segment, driven by AI CapEX, is growing fast and dominating earnings, with margins expanding significantly. Management's conservative guidance and optimistic outlook suggest potential for higher-than-expected revenue and earnings growth in 2025.
Clearside Biomedical Announces Additional Data from the CLS-AX ODYSSEY Phase 2b Trial Presented at the Angiogenesis, Exudation, and Degeneration 2025 Meeting
- BCVA and CST Data from Sub-Group Analyses Provide Key Insights for Planned CLS-AX Phase 3 Trial Design - - BCVA and CST Data from Sub-Group Analyses Provide Key Insights for Planned CLS-AX Phase 3 Trial Design -
Celestica: Room For Margin And Multiple Expansion
An SA Quant top 10 stock for 2025. Celestica's integration into the data center/AI supply chain is fueling its growth and transforming its business model with own R&D, innovation and design potencial. The company expects 22% EPS growth on expanding margins in 2025.
Similar Companies
Related Metrics
Explore detailed financial metrics and analysis for CLS.